BCL-2 Family Cell Line Panel 1 Item ID: ATCTCP2100
| Permits and Restrictions |
View Permits |
|---|---|
| Organism | Homo sapiens, human |
| Components | Neo Jurkat, ATCC CRL-2898 BCL2 Jurkat, ATCC CRL-2899 BCL2 (S70A) Jurkat, ATCC CRL-2900 BCL2 (S87A) Jurkat, ATCC CRL-2901 BCL2 (AAA) Jurkat, ATCC CRL-2902 |
| Applications |
The Cell Death Pathway BCL-2 Family Cell Line Panels 1 & 2 are useful for the study of cell apoptosis signaling pathways, BCL-2 family member molecular mechanisms, and mitochondrial dysfunction. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments |
The Cell Death Pathway BCL-2 Family Cell Line Panel 1 is composed of five Jurkat leukemia cell lines that stably overexpress either wild-type BCL-2 or a mutant form of BCL-2. The BCL-2 mutations include phosphorylation site substitutions S70A, S87A, and a triple subsitution AAA (T69A, S70A, S87A). Mutations have been sequenced and validated by ATCC. |
| Product Format | frozen 5 cryopreserved cell lines |
| Shipping Information | Frozen |
| Storage Conditions | liquid nitrogen vapor phase |
| Permits |
These permits may be required for shipping this product to Australia:
|
|---|---|
| Basic Documentation | Product Sheet Certificate of Analysis SDS |
| Other Documentation | BCL-2 Family Cell Line Data |